Predictors of timely linkage‐to‐ART within universal test and treat in the HPTN 071 (PopART) trial in Zambia and South Africa: findings from a nested case‐control study

HPTN 071 (PopART) is a three‐arm community randomized trial in Zambia and South Africa evaluating the impact of a combination HIV prevention package, including universal test and treat (UTT), on HIV incidence. This nested study examined factors associated with timely linkage‐to‐care and ART initiation (TLA) (i.e. within six‐months of referral) in the context of UTT within the intervention communities of the HPTN 071 (PopART) trial.

[1]  J. Pape,et al.  Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial , 2017, PLoS medicine.

[2]  M. J. van der Laan,et al.  Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa , 2017, JAMA.

[3]  R. Hayes,et al.  A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial , 2017, PLoS medicine.

[4]  J. Larmarange.  The impact of universal test and treat on HIV incidence in a rural South African population : ANRS 12249 TasP trial, 2012-2016 , 2016 .

[5]  C. Yiannoutsos,et al.  Facility-Level Factors Influencing Retention of Patients in HIV Care in East Africa , 2016, PloS one.

[6]  N. McGrath,et al.  Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa , 2016, AIDS care.

[7]  R. Salamon,et al.  A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa. , 2015, The New England journal of medicine.

[8]  H. Lane,et al.  Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. , 2015, The New England journal of medicine.

[9]  I. Bassett,et al.  Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002-2013: a meta-analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Fox,et al.  Attrition through Multiple Stages of Pre-Treatment and ART HIV Care in South Africa , 2014, PloS one.

[11]  Deborah Watson-Jones,et al.  HPTN 071 (PopART): Rationale and design of a cluster-randomised trial of the population impact of an HIV combination prevention intervention including universal testing and treatment – a study protocol for a cluster randomised trial , 2014, Trials.

[12]  Bryan E. Shepherd,et al.  Risk Factors for Delayed Initiation of Combination Antiretroviral Therapy in Rural North Central Nigeria , 2014, Journal of acquired immune deficiency syndromes.

[13]  Stefan Baral,et al.  A systematic review of interventions to reduce HIV-related stigma and discrimination from 2002 to 2013: how far have we come? , 2013, Journal of the International AIDS Society.

[14]  H. Tweya,et al.  Who Starts? Factors Associated with Starting Antiretroviral Therapy among Eligible Patients in Two, Public HIV Clinics in Lilongwe, Malawi , 2012, PloS one.

[15]  M. Andrasik,et al.  Feasibility, acceptability, and preliminary efficacy of the unity workshop: an internalized stigma reduction intervention for African American women living with HIV. , 2012, AIDS patient care and STDs.

[16]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[17]  S. Makombe,et al.  Barriers and facilitators to linkage to ART in primary care: a qualitative study of patients and providers in Blantyre, Malawi , 2012, Journal of the International AIDS Society.

[18]  D. Bangsberg,et al.  Antiretroviral therapy refusal among newly diagnosed HIV-infected adults , 2011, AIDS.

[19]  N. McGrath,et al.  What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi , 2010, BMC public health.

[20]  S. Jaffar,et al.  Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda , 2009, BMC public health.

[21]  Christopher Dye,et al.  Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model , 2009, The Lancet.

[22]  Maristela Monteiro,et al.  AUDIT - The alcohol use disorders identification test: guidelines for use in primary care. , 2001 .